Dishman Carbogen Amcis informs about press release

28 Oct 2021 Evaluate
Dishman Carbogen Amcis has informed that the Company's wholly owned subsidiary namely CARBOGEN AMCIS SAS, France, announces the release of a new batch for clinical trials of AGuIX Drug Product for NH TherAguix, a clinical stage company developing innovative nano medicine for the treatment of cancer. In this regard, it enclosed Press Release.

The above information is a part of company’s filings submitted to BSE.

Dishman Carbogen Amc Share Price

223.15 -5.45 (-2.38%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×